Skip to content

Monitoring of tissue perfusion during reconstructive free flap surgery

Monitoring of tissue perfusion during reconstructive free flap surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29325
Enrollment
20
Registered
2020-02-11
Start date
2020-03-02
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Defects caused by oncological resection or trauma.

Interventions

There will be no interventions in this study, it is an observational study

Sponsors

none
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients = 18 years old that are fit for surgery and scheduled to undergo free flap surgery for reconstruction of a defect caused by oncological resection or trauma will be included.

Exclusion criteria

Exclusion criteria: Pregnancy or lactation; Participation in another fluorescence imaging study investigating ICG or a targeted optical imaging agent in the near-infrared fluorescence imaging wavelength (>650 nm) within one month prior to enrollment; A known severe hepatic or renal insufficiency; A history of hyperthyroidism; An autonomous thyroid adenoma; A history of allergic reactions to ICG or Iodine

Design outcomes

Primary

MeasureTime frame
The main study parameter will be the ICG-derived fluorescence intensities during pre-, per- and post-operatively NIRF angiography. In addition, the other main study parameters are the HSI oxygenation values and thermal imaging skin temperature values observed during postoperative evaluation of the flap.

Secondary

MeasureTime frame
Secondary paramters are the correlation between observerd fluorescence intensities, oxygenation values and local skin temperature with conventional diagnostic techniques and clinical outcomes.

Contacts

Public ContactSimone Kleiss

UMCG

s.f.kleiss@umcg.nl0655256492

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)